About Civica:

Critical shortages of essential generic injectable drugs are an ongoing crisis in U.S. healthcare and have reached an all-time high. Over 300 essential medications are currently reported to be in shortage, according to industry and FDA reports.

Shortages put patients at risk and waste hospital resources.

Civica is a market-based nonprofit solution created in 2018 by health systems and philanthropies for the express purpose of preventing and mitigating drug shortages. Today, nearly 60 health systems have joined Civica, representing over 1,400 hospitals and approximately one-third of all U.S. hospital beds. Civica has also supplied the U.S. Department of Veteran’s Affairs, the U.S. Department of Defense and the U.S. Strategic National Stockpile with essential medicines. Civica currently supplies medicines to health system members in 49 states.

Civica’s mission has expanded beyond the hospital setting to reach consumers directly through CivicaScript, which is dedicated to making quality outpatient generic medicines affordable and available. CivicaScript works with trusted manufacturing partners to develop quality generic medicines and has forged partnerships with like-minded payors, pharmacy benefit managers and pharmacies to enable significant cost savings to be passed along to their customers.

Civica’s new 140,000 square foot state-of-the-art manufacturing facility in Virginia will soon produce a steady supply of more than three dozen sterile injectables, all drugs that are currently in or near shortage. The plant will also produce affordable biosimilar insulins, ensuring all Americans have access to lower cost, quality insulins, regardless of their insurance status.

The Civica Foundation is a 501(c)(3) organization that fosters philanthropic support for Civica’s work to manufacture and distribute affordable medications. The Foundation’s first commitment is to support Civica’s efforts to bring affordable insulin to all Americans. Leaders from nearly every corner of the diabetes ecosystem are partners in this initiative. 

Civica is leading a movement for patients, not profits. Because eliminating shortages and stabilizing high prices are in the best interest of patients.

Join us. Learn more at  www.civicarx.org

Job Description:

The Commercial Business Analyst - CivicaScript will play a key role in supporting CivicaScript’s strategic commercial efforts by providing data-driven insights, building financial and market models, and collaborating with cross-functional teams to drive access and affordability for essential medicines.

This person will support CivicaScript’s operational planning and execution, including working with CivicaScript members and strategic business partners to assess utilization and pricing trends, identify opportunities for improved efficiency and cost control, create risk mitigation strategies, and implement plans to reach our business goals.

Assists in overall strategic planning to drive the successful growth of the Company. This role will drive the overall scale and sustainability of CivicaScript by executing on our mission and collaborating with all Civica entities as we continue to bring innovation and solutions that are in the best interest of patients.

Essential Duties and Responsibilities:

• Support portfolio prioritization: Assist the Director of Portfolio Management in evaluations of products to be added to the CivicaScript portfolio and ensure proper prioritization for launch schedule.
• Analyze market trends, customer behavior, and sales data to inform go-to-market strategies and product launch planning.
• Develop financial models to support pricing, revenue forecasting, and cost analysis.
• Track commercial KPIs and create dashboards and reporting tools to measure performance and business impact.
• Manages data collection from external partners and ensures data accuracy.
• Analyzes complex business problems using data from internal and external sources to provide insights and recommendations to CivicaScript team.
• Contribute to the development and execution of quarterly business reviews with key external stakeholders.
• Supports efforts to develop and produce annual aggregate savings report, in partnership with external consultants.
• Assists with state licensing and transparency requirements, drug database listing, and other reporting requirements as needed.
• Fosters a success-oriented, accountable environment.
• Perform other duties as required. 

Basic Qualifications and Capabilities:

• Bachelor’s degree in Business, Finance, Economics, Data Analytics, or a related field.
• 3–5 years of experience in a commercial or business analyst role, preferably in pharmaceuticals, managed care / PBM, or life sciences.
• Experience with US generics market preferred. 
• Strong interpersonal and communication skills.
• Strong business acumen, analytic, and decision-making skills 
• Experience working effectively with limited information.
• Self-directed, team player that can easily navigate a highly matrixed organization and foster internal and external collaboration. 
• Ability to balance multiple tasks simultaneously and work in a matrixed environment.
• Extreme attention to detail and data accuracy.
• Experience using business intelligence tools such as Tableau, QlikView, etc. preferred.
• Experience with market assessment tools such as IQVIA, Medi-Span, etc. preferred.
• Proficiency in Microsoft Office platform required. 

Physical Demands and Work Environment:

• This position will be fully remote.
•  Ability to travel in the U.S., as needed. Travel of up to 10% may be required